Int J Gen Med. 2013 Dec 06;7:21-7. doi: 10.2147/IJGM.S51302. eCollection 2013.

An unusual case of malignancy-related hypercalcemia.

International journal of general medicine

Mary-Anne Doyle, Janine C Malcolm

PMID: 24353437 PMCID: PMC3862645 DOI: 10.2147/IJGM.S51302

Abstract

OBJECTIVE: To report the case of a 28-year-old woman who presented with hypercalcemia (total calcium =4.11 mmol/L), elevated parathyroid hormone (PTH) 24.6 pmol/L, normal parathyroid hormone-related peptide 7.8 pg/mL, and a 63 mm × 57 mm, poorly differentiated neuroendocrine carcinoma (small-cell type) pancreatic mass with liver metastases.

INVESTIGATIONS AND TREATMENT: Hypercalcemia was acutely managed with intravenous fluids, pamidronate and calcitonin. Investigations for multiple endocrine neoplasia type 1 and parathyroid adenoma were initiated. The identified neuroendocrine tumor was treated with cisplatinum/etoposide chemotherapy.

RESULTS: The pancreatic mass (56 mm × 49 mm) and metastases decreased in size with chemotherapy and calcium levels normalized. Eight months later, calcium increased to 3.23 mmol/L, PTH increased to 48.2 pmol/L, and the pancreatic mass increased in size to 67 mm × 58 mm. The patient was given a trial of cinacalcet but was unable to tolerate it. Chemotherapy was restarted and resulted in a decrease in the pancreatic mass (49 mm × 42 mm), a reduction in PTH levels (16.6 pmol/L), and calcium levels (2.34 mmol/L).

CONCLUSION: Ectopic PTH secreting tumors should be considered when there is no parathyroid related cause for an elevated PTH. Recognizing the association between PTH and hypercalcemia of malignancy may lead to an earlier detection of an undiagnosed malignancy.

Keywords: hypercalcemia of malignancy; neuroendocrine tumor; parathyroid hormone; parathyroid hormone related-peptide

References

1. Science. 1987 Aug 21;237(4817):893-6 - PubMed
2. N Engl J Med. 2005 Jan 27;352(4):373-9 - PubMed
3. Proc Natl Acad Sci U S A. 1987 Jul;84(14):5048-52 - PubMed
4. J Clin Endocrinol Metab. 2006 Feb;91(2):580-3 - PubMed
5. J Clin Endocrinol Metab. 1998 Aug;83(8):2653-7 - PubMed
6. Nephrol Dial Transplant. 2012 Jun;27(6):2198-205 - PubMed
7. Eur J Clin Invest. 2007 Dec;37(12):915-22 - PubMed
8. Endocrine. 2005 Jun;27(1):83-6 - PubMed
9. J Clin Invest. 1987 Dec;80(6):1803-7 - PubMed
10. Dis Mon. 2013 Jan;59(1):5-19 - PubMed
11. J Clin Endocrinol Metab. 1994 Sep;79(3):912-5 - PubMed
12. Arch Pathol Lab Med. 2005 Apr;129(4):531-3 - PubMed
13. N Engl J Med. 1990 Nov 8;323(19):1324-8 - PubMed
14. Abdom Imaging. 1999 Mar-Apr;24(2):144-6 - PubMed
15. Mod Pathol. 2007 Feb;20 Suppl 1:S94-112 - PubMed
16. Nephrol Dial Transplant. 2005 Dec;20(12):2832-5 - PubMed
17. Endocr J. 2013;60(5):557-62 - PubMed
18. Endocr Pract. 2004 Mar-Apr;10(2):125-8 - PubMed
19. N Engl J Med. 2011 Dec 22;365(25):2389-97 - PubMed
20. Endocr Pract. 2006 May-Jun;12(3):302-6 - PubMed
21. Prim Care. 2008 Jun;35(2):215-37, v-vi - PubMed
22. Endocr Pract. 2003 Sep-Oct;9(5):400-5 - PubMed
23. Int J Clin Exp Med. 2011;4(3):234-40 - PubMed
24. J Am Soc Nephrol. 2008 Apr;19(4):672-5 - PubMed
25. Metabolism. 2002 Jul;51(7):871-5 - PubMed
26. CMAJ. 2011 Jul 12;183(10):E685-9 - PubMed
27. J Thorac Cardiovasc Surg. 2006 Apr;131(4):923-4 - PubMed
28. Eur J Surg Oncol. 2006 Jun;32(5):511-5 - PubMed
29. J Biol Chem. 1987 May 25;262(15):7151-6 - PubMed
30. J Pathol. 2004 Jan;202(1):86-94 - PubMed
31. Biochim Biophys Acta. 2013 Jul;1833(7):1732-44 - PubMed
32. J Clin Endocrinol Metab. 1993 Mar;76(3):801-3 - PubMed
33. J Clin Endocrinol Metab. 1996 Oct;81(10):3793-6 - PubMed
34. Cancer Res. 2006 Sep 15;66(18):9065-73 - PubMed
35. J Clin Endocrinol Metab. 2001 Apr;86(4):1525-31 - PubMed
36. J Clin Endocrinol Metab. 1993 May;76(5):1373-5 - PubMed
37. J Clin Endocrinol Metab. 1989 May;68(5):976-81 - PubMed
38. Leuk Lymphoma. 2010 Apr;51(4):702-14 - PubMed

Publication Types

• Case Reports